Related Experiment Videos
[Hypertension in pregnancy]
1Service de médecine interne, hôpital Tenon, 4, rue de la Chine, 75970 Paris.
Insights
Preeclampsia, a pregnancy hypertension complication, poses severe risks to mothers and infants due to placental issues and endothelial dysfunction. Effective obstetrical management and early prevention are crucial for better outcomes.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Cardiovascular Research
Context:
- Hypertension complicates 10-15% of pregnancies, with 10-20% developing proteinuria, defining preeclampsia.
- Preeclampsia presents a significant threat to both fetal and maternal prognosis, exacerbated by HELLP syndrome.
- Pathophysiology involves early placentation abnormalities leading to placental ischemia and maternal endothelial dysfunction.
Purpose:
- To highlight the pathophysiology of preeclampsia, emphasizing placental ischemia and endothelial dysfunction.
- To underscore the limitations of solely lowering blood pressure in managing preeclampsia.
- To advocate for effective obstetrical management and early preventive strategies for preeclampsia.
Summary:
- Preeclampsia arises from placental ischemia causing maternal endothelial dysfunction, resulting in vasoconstriction and clotting issues.
- Antihypertensive drugs alone are often ineffective or detrimental; obstetrical management is key.
- Early preventive strategies are essential, though their specific modalities require further discussion.
Impact:
- Effective management and prevention of preeclampsia can improve maternal and fetal outcomes.
- Understanding pathophysiology guides treatment, moving beyond simple blood pressure reduction.
- Addresses the high recurrence rate of hypertension in subsequent pregnancies and links to long-term vascular risk.
Abstract:
Hypertension occurs in 10 to 15 p cent of pregnancies. Among them, 10 to 20% also have proteinuria. This situation defines preeclampsia, and involves a serious threat on foetal and even maternal prognosis. Presence of the hepatic (HELLP) syndrome still severely worsens the prognosis. Pathophysiology of preeclampsia is based on a very early abnormality of placentation, leading to insufficient blood supply to the foeto-placental unit. At the maternal level, the main consequence of placental ischemia is diffuse endothelial dysfunction, responsible for systemic vasoconstriction and clotting abnormalities. In such a context, merely lowering blood pressure with drugs is quite inefficient, or even harmful. The prognosis of this disease is mainly related to the pertinence of obstetrical management. An early preventive strategy is the most logical approach of preeclampsia, its modalities remain under discussion. Hypertension has a high recurrence rate on subsequent pregnancies. It is most often linked to a high global vascular risk level, therefore many of those patients will become permanent hypertensives in the near future.